Treatment of Hypercalcemia of Malignancy
Loading...
Date
Journal Title
Journal ISSN
Volume Title
Publisher
W.B. Saunders
Abstract
Description
Keywords
Antiresorptive therapy, Bisphosphonates, Cancer, Denosumab, Fluids, Furosemide, Hypercalcemia of malignancy, Refractory, Bone density conservation agents, Diphosphonates, Humans, Hypercalcemia, Neoplasms, Zoledronic acid, Calcitonin, Cinacalcet, Clodronic acid, Etidronic acid, Jmt 103, Monoclonal antibody, Pamidronic acid, Sodium chloride, Unclassified drug, Bisphosphonic acid derivative, Bone density conservation agent, Arthralgia, Atypical subtrochanteric femoral fracture, Bone pain, Drug efficacy, Drug potency, Drug safety, Femur subtrochanteric fracture, Fever, Fluid therapy, Human, Meta analysis, Open study, Paraneoplastic hypercalcemia, Prescription, Relapse, Review, Risk benefit analysis, Systematic review, Treatment duration, Treatment response, Complication, Neoplasm